Search Results

There are 19163 results for: content related to: Tolerability and efficacy of pegylated interferon-α-2a in combination with imatinib for patients with chronic-phase chronic myeloid leukemia

  1. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue s2, May 2012, Pages: 1–26, I. M. Jacobson, J.-M. Pawlotsky, N. H. Afdhal, G. M. Dusheiko, X. Forns, D. M. Jensen, F. Poordad and J. Schulz

    Version of Record online : 8 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01590.x

  2. You have free access to this content
    Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 6, September 2014, Pages: 657–675, S. Saab, S. C. Gordon, H. Park, M. Sulkowski, A. Ahmed and Z. Younossi

    Version of Record online : 28 JUL 2014, DOI: 10.1111/apt.12871

  3. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  4. Safety and efficacy of faldaprevir in combination with pegylated interferon α-2b and ribavirin in Japanese patients with genotype-1 chronic hepatitis C virus infection

    Hepatology Research

    Shuhei Nishiguchi, Yasuhisa Urano, Keiko Suzaki, Atsushi Taniguchi, Joseph Scherer, Kristi L. Berger, Anne-Marie Quinson, Jerry O. Stern and Masao Omata

    Version of Record online : 10 AUG 2016, DOI: 10.1111/hepr.12741

  5. You have free access to this content
    Poster Session 4: Stem Cell Biology; Varices and Bleeding

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 1195A–1215A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28243

  6. Therapy for hepatitis C genotype 3: moving forward

    Journal of Viral Hepatitis

    Volume 22, Issue 9, September 2015, Pages: 683–690, M. Buti, J. Llaneras, M. Riveiro-Barciela and R. Esteban

    Version of Record online : 13 MAY 2015, DOI: 10.1111/jvh.12419

  7. You have free access to this content
    An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

    Hepatology

    Volume 54, Issue 4, October 2011, Pages: 1433–1444, Marc G. Ghany, David R. Nelson, Doris B. Strader, David L. Thomas and Leonard B. Seeff

    Version of Record online : 26 SEP 2011, DOI: 10.1002/hep.24641

  8. You have free access to this content
    Response-guided therapy in patients with genotype 1 hepatitis C virus: Current status and future prospects

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 8, August 2014, Pages: 1574–1581, Eric J Lawitz and Fernando E Membreno

    Version of Record online : 29 JUL 2014, DOI: 10.1111/jgh.12632

  9. You have free access to this content
    Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver

    Liver International

    Volume 32, Issue 10, November 2012, Pages: 1477–1492, Vincent Leroy, Lawrence Serfaty, Marc Bourlière, Jean-Pierre Bronowicki, Patrick Delasalle, Alexandre Pariente, Stanislas Pol, Fabien Zoulim and Georges-Philippe Pageaux

    Version of Record online : 14 AUG 2012, DOI: 10.1111/j.1478-3231.2012.02856.x

  10. You have free access to this content
    Faldaprevir combined with peginterferon alfa-2a and ribavirin in chronic hepatitis C virus genotype-1 patients with prior nonresponse: SILEN-C2 trial

    Hepatology

    Volume 57, Issue 6, June 2013, Pages: 2155–2163, Mark S. Sulkowski, Marc Bourlière, Jean-Pierre Bronowicki, Tarik Asselah, Jean-Michel Pawlotsky, Stephen D. Shafran, Stanislas Pol, Stefan Mauss, Dominique Larrey, Yakov Datsenko, Jerry O. Stern, George Kukolj, Joseph Scherer, Gerhard Nehmiz, Gerhard G. Steinmann and Wulf O. Böcher

    Version of Record online : 12 JUN 2013, DOI: 10.1002/hep.26386

  11. You have free access to this content
    Review article: specifically targeted anti-viral therapy for hepatitis C – a new era in therapy

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 1, July 2010, Pages: 14–28, C. M. Lange, C. Sarrazin and S. Zeuzem

    Version of Record online : 31 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04317.x

  12. You have free access to this content
    Faldaprevir combined with pegylated interferon alfa-2a and ribavirin in treatment-naïve patients with chronic genotype1 HCV: SILEN-C1 trial

    Hepatology

    Volume 57, Issue 6, June 2013, Pages: 2143–2154, Mark S. Sulkowski, Tarik Asselah, Jacob Lalezari, Peter Ferenci, Hugo Fainboim, Barbara Leggett, Fernando Bessone, Stefan Mauss, Jeong Heo, Yakov Datsenko, Jerry O. Stern, George Kukolj, Joseph Scherer, Gerhard Nehmiz, Gerhard G. Steinmann and Wulf O. Böcher

    Version of Record online : 12 JUN 2013, DOI: 10.1002/hep.26276

  13. Role of Pegylated Interferon-α-2a and Ribavirin Concentrations in Sustained Viral Response in HCV/HIV-Coinfected Patients

    Clinical Pharmacology & Therapeutics

    Volume 84, Issue 5, November 2008, Pages: 573–580, LF Lopez-Cortes, B Valera-Bestard, A Gutierrez-Valencia, R Ruiz-Valderas, L Jimenez, A Arizcorreta, A Terrón and P Viciana

    Version of Record online : 2 JUL 2008, DOI: 10.1038/clpt.2008.110

  14. You have free access to this content
    Pegylated interferon-associated retinopathy is frequent in hepatitis C virus patients with hypertension and justifies ophthalmologic screening

    Hepatology

    Volume 56, Issue 2, August 2012, Pages: 455–463, Stela Vujosevic, Diego Tempesta, Franco Noventa, Edoardo Midena and Giada Sebastiani

    Version of Record online : 11 JUN 2012, DOI: 10.1002/hep.25654

  15. You have free access to this content
    Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha

    Hepatology

    Volume 46, Issue 2, August 2007, Pages: 371–379, Mitchell L. Shiffman, Jennifer Salvatore, Sarah Hubbard, Angie Price, Richard K. Sterling, R. Todd Stravitz, Velimir A. Luketic and Arun J. Sanyal

    Version of Record online : 8 JUN 2007, DOI: 10.1002/hep.21712

  16. You have free access to this content
    Avoiding and managing lamivudine resistance in chronic hepatitis B: current approaches and potential strategies including pegylated interferon

    Liver International

    Volume 30, Issue 5, May 2010, Pages: 657–668, Patrick Marcellin, Joseph Sung and Teerha Piratvisuth

    Version of Record online : 15 FEB 2010, DOI: 10.1111/j.1478-3231.2010.02207.x

  17. Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa-2b in HBeAg-positive patients

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 9, September 2010, Pages: 1498–1506, Hui Ma, Rui-feng Yang and Lai Wei

    Version of Record online : 3 FEB 2010, DOI: 10.1111/j.1440-1746.2010.06282.x

  18. Comparison of quality of life, work productivity and medical resource utilization of peginterferon alpha 2a vs the combination of interferon alpha 2b plus ribavirin as initial treatment in patients with chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 11, Issue 2, March 2004, Pages: 157–165, R. Perrillo, K. D. Rothstein, R. Rubin, I. Alam, J. Imperial, G. Harb, S. Hu and W. Klaskala

    Version of Record online : 20 FEB 2004, DOI: 10.1046/j.1365-2893.2003.00482.x

  19. Baseline HBsAg and HBcrAg titres allow peginterferon-based ‘precision medicine’ in HBeAg-negative chronic hepatitis B patients

    Journal of Viral Hepatitis

    M. Martinot-Peignoux, M. Lapalus, S. Maylin, N. Boyer, C. Castelnau, N. Giuily, M. Pouteau, R. Moucari, T. Asselah and P. Marcellin

    Version of Record online : 4 JUL 2016, DOI: 10.1111/jvh.12565

  20. You have free access to this content
    Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients

    Hepatology

    Volume 55, Issue 1, January 2012, Pages: 39–48, Birgit Edlich, Golo Ahlenstiel, Aintzane Azpiroz Zabaleta, Jonathan Stoltzfus, Mazen Noureddin, Elisavet Serti, Jordan J. Feld, T. Jake Liang, Yaron Rotman and Barbara Rehermann

    Version of Record online : 14 NOV 2011, DOI: 10.1002/hep.24628